Altre lingue Biofrontera Inc.

Azioni

BFRI

US09077D2099

Tempo differito Nasdaq Altri mercati azionari 19:42:27 02/05/2024			Variaz. 5gg	Var. 1 gen.
1,89 ^USD	-3,57%		+11,83%	-31,77%

18/03	Transcript : Biofrontera Inc., Q4 2023 Earnings Call, Mar 18, 2024
15/03	Biofrontera Inc. riporta i risultati degli utili per il quarto trimestre conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Biofrontera : Certificate of Incorporation/Bylaws - Form 8-K	11:02
Biofrontera Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	15/03
Biofrontera Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Biofrontera Files Prospectus for Potential Secondary Stock Offerings	11/03
Medicus Pharma Names COO	05/03
Biofrontera Inc. announced that it has received $8 million in funding	22/02
BIOFRONTERA AG ANNOUNCES REVISED STRATEGY	21/02
BIOFRONTERA AG, BIOFRONTERA TRANSFERS CLINICAL RESEARCH TO THE U.S.	21/02
Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera Ag	20/02
Biofrontera Inc. announced that it expects to receive $8 million in funding	19/02
MORNING BRIEFING - Deutschland/Europa -2-	16/02
Biofrontera Inc. Announces FDA Filing of Supplemental New Drug Application for Ameluz(R) to Permit Up to Three Tubes Per Use	05/02
Certain Warrants of Biofrontera Inc. are subject to a Lock-Up Agreement Ending on 1-FEB-2024.	01/02
Certain Common Stock of Biofrontera Inc. are subject to a Lock-Up Agreement Ending on 1-FEB-2024.	01/02
Certain Stock options of Biofrontera Inc. are subject to a Lock-Up Agreement Ending on 1-FEB-2024.	01/02
Biofrontera Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023	11/01
Biofrontera Inc. Terminates MidCap Business Credit Loan Agreement	09/01
Biofrontera Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Biofrontera Inc. Reaffirms Revenue Guidance for the Full Year 2023	09/11
Earnings Flash (BFRI) BIOFRONTERA Reports Q3 Revenue $8.9M, vs. Street Est of $8.4M	09/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Biofrontera Inc.

Azioni

BFRI

US09077D2099

Altre lingue

Filtri